Correlation Between S A P and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both S A P and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining S A P and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAP SE and AstraZeneca PLC, you can compare the effects of market volatilities on S A P and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in S A P with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of S A P and AstraZeneca PLC.

Diversification Opportunities for S A P and AstraZeneca PLC

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SAP and AstraZeneca is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding SAP SE and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and S A P is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAP SE are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of S A P i.e., S A P and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between S A P and AstraZeneca PLC

Assuming the 90 days trading horizon SAP SE is expected to generate 0.8 times more return on investment than AstraZeneca PLC. However, SAP SE is 1.25 times less risky than AstraZeneca PLC. It trades about 0.22 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.09 per unit of risk. If you would invest  20,065  in SAP SE on September 17, 2024 and sell it today you would earn a total of  4,000  from holding SAP SE or generate 19.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.48%
ValuesDaily Returns

SAP SE  vs.  AstraZeneca PLC

 Performance 
       Timeline  
SAP SE 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in SAP SE are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, S A P unveiled solid returns over the last few months and may actually be approaching a breakup point.
AstraZeneca PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

S A P and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with S A P and AstraZeneca PLC

The main advantage of trading using opposite S A P and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if S A P position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind SAP SE and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges